Cell Therapy Market Report

Global and Regional Cell Therapy Market Details Research Report 2021-2026

  • POSTDATE：Jun 25, 2021
  • PAGES：188
  • REPORT CODE：GMM719424
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Cell Therapy Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive Cell Therapy market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global Cell Therapy market.

    By Player:

    • MEDIPOST

    • ANTEROGENCO LTD

    • Advanced Tissue

    • Grupo Praxis

    • JCR Pharmaceuticals CO LTD

    • NuVasive Inc

    • EUFETS GmbH

    • PHARMICELL

    • Genzyme Corporation

    • GlaxoSmithKline plc

    • Pluristem

    • Cynata

    • BioNTech IMFS

    • Cognate

    • CELLECTIS

    • Osiris

    • Dendreon

    • Mesoblast

    • Novartis AG

    • Vericel

    By Type:

    • Autologous

    • Allogeneic

    By End-User:

    • Hospitals and clinics

    • ASCs

    • Regenerative medicine centers

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 Cell Therapy Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global Cell Therapy Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global Cell Therapy Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global Cell Therapy Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global Cell Therapy Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers Cell Therapy Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 MEDIPOST

      • 3.1.1 MEDIPOST - Company Business Overview

      • 3.1.2 MEDIPOST - Company Financial Performance

      • 3.1.3 MEDIPOST - Company Financial Performance of Cell Therapy

      • 3.1.4 Cell Therapy Product Benchmarking

      • 3.1.5 Strategic Initiatives

    • 3.2 ANTEROGENCO LTD

      • 3.2.1 ANTEROGENCO LTD - Company Business Overview

      • 3.2.2 ANTEROGENCO LTD - Company Financial Performance

      • 3.2.3 ANTEROGENCO LTD - Company Financial Performance of Cell Therapy

      • 3.2.4 Cell Therapy Product Benchmarking

      • 3.2.5 Strategic Initiatives

    • 3.3 Advanced Tissue

      • 3.3.1 Advanced Tissue - Company Business Overview

      • 3.3.2 Advanced Tissue - Company Financial Performance

      • 3.3.3 Advanced Tissue - Company Financial Performance of Cell Therapy

      • 3.3.4 Cell Therapy Product Benchmarking

      • 3.3.5 Strategic Initiatives

    • 3.4 Grupo Praxis

      • 3.4.1 Grupo Praxis - Company Business Overview

      • 3.4.2 Grupo Praxis - Company Financial Performance

      • 3.4.3 Grupo Praxis - Company Financial Performance of Cell Therapy

      • 3.4.4 Cell Therapy Product Benchmarking

      • 3.4.5 Strategic Initiatives

    • 3.5 JCR Pharmaceuticals CO LTD

      • 3.5.1 JCR Pharmaceuticals CO LTD - Company Business Overview

      • 3.5.2 JCR Pharmaceuticals CO LTD - Company Financial Performance

      • 3.5.3 JCR Pharmaceuticals CO LTD - Company Financial Performance of Cell Therapy

      • 3.5.4 Cell Therapy Product Benchmarking

      • 3.5.5 Strategic Initiatives

    • 3.6 NuVasive Inc

      • 3.6.1 NuVasive Inc - Company Business Overview

      • 3.6.2 NuVasive Inc - Company Financial Performance

      • 3.6.3 NuVasive Inc - Company Financial Performance of Cell Therapy

      • 3.6.4 Cell Therapy Product Benchmarking

      • 3.6.5 Strategic Initiatives

    • 3.7 EUFETS GmbH

      • 3.7.1 EUFETS GmbH - Company Business Overview

      • 3.7.2 EUFETS GmbH - Company Financial Performance

      • 3.7.3 EUFETS GmbH - Company Financial Performance of Cell Therapy

      • 3.7.4 Cell Therapy Product Benchmarking

      • 3.7.5 Strategic Initiatives

    • 3.8 PHARMICELL

      • 3.8.1 PHARMICELL - Company Business Overview

      • 3.8.2 PHARMICELL - Company Financial Performance

      • 3.8.3 PHARMICELL - Company Financial Performance of Cell Therapy

      • 3.8.4 Cell Therapy Product Benchmarking

      • 3.8.5 Strategic Initiatives

    • 3.9 Genzyme Corporation

      • 3.9.1 Genzyme Corporation - Company Business Overview

      • 3.9.2 Genzyme Corporation - Company Financial Performance

      • 3.9.3 Genzyme Corporation - Company Financial Performance of Cell Therapy

      • 3.9.4 Cell Therapy Product Benchmarking

      • 3.9.5 Strategic Initiatives

    • 3.10 GlaxoSmithKline plc

      • 3.10.1 GlaxoSmithKline plc - Company Business Overview

      • 3.10.2 GlaxoSmithKline plc - Company Financial Performance

      • 3.10.3 GlaxoSmithKline plc - Company Financial Performance of Cell Therapy

      • 3.10.4 Cell Therapy Product Benchmarking

      • 3.10.5 Strategic Initiatives

    • 3.11 Pluristem

      • 3.11.1 Pluristem - Company Business Overview

      • 3.11.2 Pluristem - Company Financial Performance

      • 3.11.3 Pluristem - Company Financial Performance of Cell Therapy

      • 3.11.4 Cell Therapy Product Benchmarking

      • 3.11.5 Strategic Initiatives

    • 3.12 Cynata

      • 3.12.1 Cynata - Company Business Overview

      • 3.12.2 Cynata - Company Financial Performance

      • 3.12.3 Cynata - Company Financial Performance of Cell Therapy

      • 3.12.4 Cell Therapy Product Benchmarking

      • 3.12.5 Strategic Initiatives

    • 3.13 BioNTech IMFS

      • 3.13.1 BioNTech IMFS - Company Business Overview

      • 3.13.2 BioNTech IMFS - Company Financial Performance

      • 3.13.3 BioNTech IMFS - Company Financial Performance of Cell Therapy

      • 3.13.4 Cell Therapy Product Benchmarking

      • 3.13.5 Strategic Initiatives

    • 3.14 Cognate

      • 3.14.1 Cognate - Company Business Overview

      • 3.14.2 Cognate - Company Financial Performance

      • 3.14.3 Cognate - Company Financial Performance of Cell Therapy

      • 3.14.4 Cell Therapy Product Benchmarking

      • 3.14.5 Strategic Initiatives

    • 3.15 CELLECTIS

      • 3.15.1 CELLECTIS - Company Business Overview

      • 3.15.2 CELLECTIS - Company Financial Performance

      • 3.15.3 CELLECTIS - Company Financial Performance of Cell Therapy

      • 3.15.4 Cell Therapy Product Benchmarking

      • 3.15.5 Strategic Initiatives

    • 3.16 Osiris

      • 3.16.1 Osiris - Company Business Overview

      • 3.16.2 Osiris - Company Financial Performance

      • 3.16.3 Osiris - Company Financial Performance of Cell Therapy

      • 3.16.4 Cell Therapy Product Benchmarking

      • 3.16.5 Strategic Initiatives

    • 3.17 Dendreon

      • 3.17.1 Dendreon - Company Business Overview

      • 3.17.2 Dendreon - Company Financial Performance

      • 3.17.3 Dendreon - Company Financial Performance of Cell Therapy

      • 3.17.4 Cell Therapy Product Benchmarking

      • 3.17.5 Strategic Initiatives

    • 3.18 Mesoblast

      • 3.18.1 Mesoblast - Company Business Overview

      • 3.18.2 Mesoblast - Company Financial Performance

      • 3.18.3 Mesoblast - Company Financial Performance of Cell Therapy

      • 3.18.4 Cell Therapy Product Benchmarking

      • 3.18.5 Strategic Initiatives

    • 3.19 Novartis AG

      • 3.19.1 Novartis AG - Company Business Overview

      • 3.19.2 Novartis AG - Company Financial Performance

      • 3.19.3 Novartis AG - Company Financial Performance of Cell Therapy

      • 3.19.4 Cell Therapy Product Benchmarking

      • 3.19.5 Strategic Initiatives

    • 3.20 Vericel

      • 3.20.1 Vericel - Company Business Overview

      • 3.20.2 Vericel - Company Financial Performance

      • 3.20.3 Vericel - Company Financial Performance of Cell Therapy

      • 3.20.4 Cell Therapy Product Benchmarking

      • 3.20.5 Strategic Initiatives

    4 Global Cell Therapy Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global Cell Therapy Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of Autologous 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of Allogeneic 2016-2021

    • 4.3 Global Cell Therapy Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of Autologous 2016-2021

      • 4.3.2 Global Sales and Growth Rate of Allogeneic 2016-2021

    • 4.4 Global Cell Therapy Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global Cell Therapy Market Sales and Market Share by Types (Forecast)

    • 4.6 Global Cell Therapy Market Price By Type from 2016 to 2026

    5 Global Cell Therapy Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of Cell Therapy

    • 5.2 Global Cell Therapy Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Hospitals and clinics 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of ASCs 2016-2021

      • 5.2.3 Global Revenue and Growth Rate of Regenerative medicine centers 2016-2021

    • 5.3 Global Cell Therapy Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Hospitals and clinics 2016-2021

      • 5.3.2 Global Sales and Growth Rate of ASCs 2016-2021

      • 5.3.3 Global Sales and Growth Rate of Regenerative medicine centers 2016-2021

    • 5.4 Global Cell Therapy Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global Cell Therapy Market Sales and Market Share by Application (Forecast)

    6 Global Cell Therapy Market Segment Analysis (Geography Level)

    • 6.1 Global Cell Therapy Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global Cell Therapy Market Sales and Market Share by Geography (Historical)

    • 6.3 Global Cell Therapy Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global Cell Therapy Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in Cell Therapy Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in Cell Therapy Market from 2016 to 2020

    7. North America Cell Therapy Market Segment Analysis and Investment Attractiveness

    • 7.1 North America Cell Therapy Market Segment by Countries

      • 7.1.1 North America Cell Therapy Market Revenue Segment by Countries

      • 7.1.2 North America Cell Therapy Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America Cell Therapy Market Segment (Product Type Level)

    • 7.3 North America Cell Therapy Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe Cell Therapy Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe Cell Therapy Market Segment by Countries

      • 8.1.1 Europe Cell Therapy Market Revenue Segment by Countries

      • 8.1.2 Europe Cell Therapy Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe Cell Therapy Market Segment (Product Type Level)

    • 8.3 Europe Cell Therapy Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia Cell Therapy Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia Cell Therapy Market Segment by Countries

      • 9.1.1 Asia Cell Therapy Market Revenue Segment by Countries

      • 9.1.2 Asia Cell Therapy Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia Cell Therapy Market Segment (Product Type Level)

    • 9.3 Asia Cell Therapy Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America Cell Therapy Market Segment Analysis and Investment Attractiveness

    • 10.1 South America Cell Therapy Market Segment by Countries

      • 10.1.1 South America Cell Therapy Market Revenue Segment by Countries

      • 10.1.2 South America Cell Therapy Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America Cell Therapy Market Segment (Product Type Level)

    • 10.3 South America Cell Therapy Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East Cell Therapy Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East Cell Therapy Market Segment by Countries

      • 11.1.1 Middle East Cell Therapy Market Revenue Segment by Countries

      • 11.1.2 Middle East Cell Therapy Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East Cell Therapy Market Segment (Product Type Level)

    • 11.3 Middle East Cell Therapy Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa Cell Therapy Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa Cell Therapy Market Segment by Countries

      • 12.1.1 Africa Cell Therapy Market Revenue Segment by Countries

      • 12.1.2 Africa Cell Therapy Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa Cell Therapy Market Segment (Product Type Level)

    • 12.3 Africa Cell Therapy Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania Cell Therapy Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania Cell Therapy Market Segment by Countries

      • 13.1.1 Oceania Cell Therapy Market Revenue Segment by Countries

      • 13.1.2 Oceania Cell Therapy Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania Cell Therapy Market Segment (Product Type Level)

    • 13.3 Oceania Cell Therapy Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 Cell Therapy Production Analysis

      • 14.2.1 Manufacturing Cost Structure of Cell Therapy

      • 14.2.2 Manufacturing Process Analysis of Cell Therapy

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of Cell Therapy Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 Cell Therapy Industry Market Status, Pre-COVID-19

      • 15.5.3 Cell Therapy Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 Cell Therapy Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure Cell Therapy Product Picture

    • Table Cell Therapy Product Definition

    • Table Study Scope by Types

    • Figure Global Cell Therapy Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global Cell Therapy Market Value by Application (2016 - 2026)

    • Figure Global Cell Therapy Market Size and Growth Rate from 2016 to 2026

    • Table Global Cell Therapy Production Capacity by Manufacturers (2016-2021)

    • Table Global Cell Therapy Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global Cell Therapy Revenue by Manufacturers (2016-2021)

    • Table Global Cell Therapy Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers Cell Therapy Plant Distribution and Sales Country

    • Table MEDIPOST - Company Business Overview

    • Figure MEDIPOST Total Revenue from 2018 to 2020

    • Table MEDIPOST Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure MEDIPOST Sales and Growth Rate Analysis of Cell Therapy

    • Figure Revenue and Market Share Analysis of MEDIPOST

    • Table Cell Therapy Product Benchmarking

    • Table ANTEROGENCO LTD - Company Business Overview

    • Figure ANTEROGENCO LTD Total Revenue from 2018 to 2020

    • Table ANTEROGENCO LTD Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure ANTEROGENCO LTD Sales and Growth Rate Analysis of Cell Therapy

    • Figure Revenue and Market Share Analysis of ANTEROGENCO LTD

    • Table Cell Therapy Product Benchmarking

    • Table Advanced Tissue - Company Business Overview

    • Figure Advanced Tissue Total Revenue from 2018 to 2020

    • Table Advanced Tissue Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Advanced Tissue Sales and Growth Rate Analysis of Cell Therapy

    • Figure Revenue and Market Share Analysis of Advanced Tissue

    • Table Cell Therapy Product Benchmarking

    • Table Grupo Praxis - Company Business Overview

    • Figure Grupo Praxis Total Revenue from 2018 to 2020

    • Table Grupo Praxis Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Grupo Praxis Sales and Growth Rate Analysis of Cell Therapy

    • Figure Revenue and Market Share Analysis of Grupo Praxis

    • Table Cell Therapy Product Benchmarking

    • Table JCR Pharmaceuticals CO LTD - Company Business Overview

    • Figure JCR Pharmaceuticals CO LTD Total Revenue from 2018 to 2020

    • Table JCR Pharmaceuticals CO LTD Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure JCR Pharmaceuticals CO LTD Sales and Growth Rate Analysis of Cell Therapy

    • Figure Revenue and Market Share Analysis of JCR Pharmaceuticals CO LTD

    • Table Cell Therapy Product Benchmarking

    • Table NuVasive Inc - Company Business Overview

    • Figure NuVasive Inc Total Revenue from 2018 to 2020

    • Table NuVasive Inc Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure NuVasive Inc Sales and Growth Rate Analysis of Cell Therapy

    • Figure Revenue and Market Share Analysis of NuVasive Inc

    • Table Cell Therapy Product Benchmarking

    • Table EUFETS GmbH - Company Business Overview

    • Figure EUFETS GmbH Total Revenue from 2018 to 2020

    • Table EUFETS GmbH Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure EUFETS GmbH Sales and Growth Rate Analysis of Cell Therapy

    • Figure Revenue and Market Share Analysis of EUFETS GmbH

    • Table Cell Therapy Product Benchmarking

    • Table PHARMICELL - Company Business Overview

    • Figure PHARMICELL Total Revenue from 2018 to 2020

    • Table PHARMICELL Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure PHARMICELL Sales and Growth Rate Analysis of Cell Therapy

    • Figure Revenue and Market Share Analysis of PHARMICELL

    • Table Cell Therapy Product Benchmarking

    • Table Genzyme Corporation - Company Business Overview

    • Figure Genzyme Corporation Total Revenue from 2018 to 2020

    • Table Genzyme Corporation Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Genzyme Corporation Sales and Growth Rate Analysis of Cell Therapy

    • Figure Revenue and Market Share Analysis of Genzyme Corporation

    • Table Cell Therapy Product Benchmarking

    • Table GlaxoSmithKline plc - Company Business Overview

    • Figure GlaxoSmithKline plc Total Revenue from 2018 to 2020

    • Table GlaxoSmithKline plc Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure GlaxoSmithKline plc Sales and Growth Rate Analysis of Cell Therapy

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline plc

    • Table Cell Therapy Product Benchmarking

    • Table Pluristem - Company Business Overview

    • Figure Pluristem Total Revenue from 2018 to 2020

    • Table Pluristem Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Pluristem Sales and Growth Rate Analysis of Cell Therapy

    • Figure Revenue and Market Share Analysis of Pluristem

    • Table Cell Therapy Product Benchmarking

    • Table Cynata - Company Business Overview

    • Figure Cynata Total Revenue from 2018 to 2020

    • Table Cynata Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Cynata Sales and Growth Rate Analysis of Cell Therapy

    • Figure Revenue and Market Share Analysis of Cynata

    • Table Cell Therapy Product Benchmarking

    • Table BioNTech IMFS - Company Business Overview

    • Figure BioNTech IMFS Total Revenue from 2018 to 2020

    • Table BioNTech IMFS Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure BioNTech IMFS Sales and Growth Rate Analysis of Cell Therapy

    • Figure Revenue and Market Share Analysis of BioNTech IMFS

    • Table Cell Therapy Product Benchmarking

    • Table Cognate - Company Business Overview

    • Figure Cognate Total Revenue from 2018 to 2020

    • Table Cognate Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Cognate Sales and Growth Rate Analysis of Cell Therapy

    • Figure Revenue and Market Share Analysis of Cognate

    • Table Cell Therapy Product Benchmarking

    • Table CELLECTIS - Company Business Overview

    • Figure CELLECTIS Total Revenue from 2018 to 2020

    • Table CELLECTIS Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure CELLECTIS Sales and Growth Rate Analysis of Cell Therapy

    • Figure Revenue and Market Share Analysis of CELLECTIS

    • Table Cell Therapy Product Benchmarking

    • Table Osiris - Company Business Overview

    • Figure Osiris Total Revenue from 2018 to 2020

    • Table Osiris Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Osiris Sales and Growth Rate Analysis of Cell Therapy

    • Figure Revenue and Market Share Analysis of Osiris

    • Table Cell Therapy Product Benchmarking

    • Table Dendreon - Company Business Overview

    • Figure Dendreon Total Revenue from 2018 to 2020

    • Table Dendreon Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Dendreon Sales and Growth Rate Analysis of Cell Therapy

    • Figure Revenue and Market Share Analysis of Dendreon

    • Table Cell Therapy Product Benchmarking

    • Table Mesoblast - Company Business Overview

    • Figure Mesoblast Total Revenue from 2018 to 2020

    • Table Mesoblast Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Mesoblast Sales and Growth Rate Analysis of Cell Therapy

    • Figure Revenue and Market Share Analysis of Mesoblast

    • Table Cell Therapy Product Benchmarking

    • Table Novartis AG - Company Business Overview

    • Figure Novartis AG Total Revenue from 2018 to 2020

    • Table Novartis AG Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Novartis AG Sales and Growth Rate Analysis of Cell Therapy

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Cell Therapy Product Benchmarking

    • Table Vericel - Company Business Overview

    • Figure Vericel Total Revenue from 2018 to 2020

    • Table Vericel Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Vericel Sales and Growth Rate Analysis of Cell Therapy

    • Figure Revenue and Market Share Analysis of Vericel

    • Table Cell Therapy Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global Cell Therapy Market Revenue by Types (Historical)

    • Table Global Cell Therapy Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of Autologous 2016-2021

    • Figure Global Revenue and Growth Rate of Allogeneic 2016-2021

    • Table Global Cell Therapy Market Sales by Types (Historical)

    • Table Global Cell Therapy Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of Autologous 2016-2021

    • Figure Global Sales and Growth Rate of Allogeneic 2016-2021

    • Table Global Cell Therapy Market Revenue by Types (Forecast)

    • Table Global Cell Therapy Market Revenue Market Share by Types (Forecast)

    • Table Global Cell Therapy Market Sales by Types (Forecast)

    • Table Global Cell Therapy Market Sales Market Share by Types (Forecast)

    • Figure Global Cell Therapy Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for Cell Therapy

    • Table Global Cell Therapy Market Revenue by Application (Historical)

    • Table Global Cell Therapy Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Hospitals and clinics 2016-2021

    • Figure Global Revenue and Growth Rate of ASCs 2016-2021

    • Figure Global Revenue and Growth Rate of Regenerative medicine centers 2016-2021

    • Table Global Cell Therapy Market Sales by Application (Historical)

    • Table Global Cell Therapy Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Hospitals and clinics 2016-2021

    • Figure Global Sales and Growth Rate of ASCs 2016-2021

    • Figure Global Sales and Growth Rate of Regenerative medicine centers 2016-2021

    • Table Global Cell Therapy Market Revenue by Application (Forecast)

    • Table Global Cell Therapy Market Revenue Market Share by Application (Forecast)

    • Table Global Cell Therapy Market Sales by Application (Forecast)

    • Table Global Cell Therapy Market Sales Market Share by Application (Forecast)

    • Table Global Cell Therapy Market Revenue by Geography (Historical)

    • Table Global Cell Therapy Market Revenue Market Share by Geography (Historical)

    • Figure Global Cell Therapy Revenue Market Share by Geography in 2020

    • Table Global Cell Therapy Market Sales by Geography (Historical)

    • Table Global Cell Therapy Market Sales Market Share by Geography (Historical)

    • Figure Global Cell Therapy Sales Market Share by Geography in 2020

    • Table Global Cell Therapy Market Revenue by Geography (Forecast)

    • Table Global Cell Therapy Market Revenue Market Share by Geography (Forecast)

    • Table Global Cell Therapy Market Sales by Geography (Forecast)

    • Table Global Cell Therapy Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America Cell Therapy Revenue by Countries from 2016 to 2026

    • Table North America Cell Therapy Revenue Market Share by Countries from 2016 to 2026

    • Figure North America Cell Therapy Revenue Market Share by Major Countries in 2020

    • Table North America Cell Therapy Sales by Countries from 2016 to 2026

    • Table North America Cell Therapy Sales Market Share by Countries from 2016 to 2026

    • Figure North America Cell Therapy Sales Market Share by Major Countries in 2020

    • Figure USA Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure USA Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Canada Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Table North America Cell Therapy Sales by Types from 2016 to 2026

    • Table North America Cell Therapy Sales Market Share by Types from 2016 to 2026

    • Table North America Cell Therapy Value by Types from 2016 to 2026

    • Table North America Cell Therapy Value Market Share by Types from 2016 to 2026

    • Table North America Cell Therapy Sales by Application from 2016 to 2026

    • Table North America Cell Therapy Sales Market Share by Application from 2016 to 2026

    • Table North America Cell Therapy Value by Application from 2016 to 2026

    • Table North America Cell Therapy Value Market Share by Application from 2016 to 2026

    • Table Europe Cell Therapy Revenue by Countries from 2016 to 2026

    • Table Europe Cell Therapy Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe Cell Therapy Revenue Market Share by Major Countries in 2020

    • Table Europe Cell Therapy Sales by Countries from 2016 to 2026

    • Table Europe Cell Therapy Sales Market Share by Countries from 2016 to 2026

    • Figure Europe Cell Therapy Sales Market Share by Major Countries in 2020

    • Figure Germany Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Germany Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure France Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure France Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Italy Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Russia Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Spain Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Poland Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Austria Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Others Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Table Europe Cell Therapy Sales by Types from 2016 to 2026

    • Table Europe Cell Therapy Sales Market Share by Types from 2016 to 2026

    • Table Europe Cell Therapy Value by Types from 2016 to 2026

    • Table Europe Cell Therapy Value Market Share by Types from 2016 to 2026

    • Table Europe Cell Therapy Sales by Application from 2016 to 2026

    • Table Europe Cell Therapy Sales Market Share by Application from 2016 to 2026

    • Table Europe Cell Therapy Value by Application from 2016 to 2026

    • Table Europe Cell Therapy Value Market Share by Application from 2016 to 2026

    • Table Asia Cell Therapy Revenue by Countries from 2016 to 2026

    • Table Asia Cell Therapy Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia Cell Therapy Revenue Market Share by Major Countries in 2020

    • Table Asia Cell Therapy Sales by Countries from 2016 to 2026

    • Table Asia Cell Therapy Sales Market Share by Countries from 2016 to 2026

    • Figure Asia Cell Therapy Sales Market Share by Major Countries in 2020

    • Figure China Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure China Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Japan Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure India Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure India Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Others Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Table Asia Cell Therapy Sales by Types from 2016 to 2026

    • Table Asia Cell Therapy Sales Market Share by Types from 2016 to 2026

    • Table Asia Cell Therapy Value by Types from 2016 to 2026

    • Table Asia Cell Therapy Value Market Share by Types from 2016 to 2026

    • Table Asia Cell Therapy Sales by Application from 2016 to 2026

    • Table Asia Cell Therapy Sales Market Share by Application from 2016 to 2026

    • Table Asia Cell Therapy Value by Application from 2016 to 2026

    • Table Asia Cell Therapy Value Market Share by Application from 2016 to 2026

    • Table South America Cell Therapy Revenue by Countries from 2016 to 2026

    • Table South America Cell Therapy Revenue Market Share by Countries from 2016 to 2026

    • Figure South America Cell Therapy Revenue Market Share by Major Countries in 2020

    • Table South America Cell Therapy Sales by Countries from 2016 to 2026

    • Table South America Cell Therapy Sales Market Share by Countries from 2016 to 2026

    • Figure South America Cell Therapy Sales Market Share by Major Countries in 2020

    • Figure Brazil Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Chile Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Others Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Table South America Cell Therapy Sales by Types from 2016 to 2026

    • Table South America Cell Therapy Sales Market Share by Types from 2016 to 2026

    • Table South America Cell Therapy Value by Types from 2016 to 2026

    • Table South America Cell Therapy Value Market Share by Types from 2016 to 2026

    • Table South America Cell Therapy Sales by Application from 2016 to 2026

    • Table South America Cell Therapy Sales Market Share by Application from 2016 to 2026

    • Table South America Cell Therapy Value by Application from 2016 to 2026

    • Table South America Cell Therapy Value Market Share by Application from 2016 to 2026

    • Table Middle East Cell Therapy Revenue by Countries from 2016 to 2026

    • Table Middle East Cell Therapy Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East Cell Therapy Revenue Market Share by Major Countries in 2020

    • Table Middle East Cell Therapy Sales by Countries from 2016 to 2026

    • Table Middle East Cell Therapy Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East Cell Therapy Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Others Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East Cell Therapy Sales by Types from 2016 to 2026

    • Table Middle East Cell Therapy Sales Market Share by Types from 2016 to 2026

    • Table Middle East Cell Therapy Value by Types from 2016 to 2026

    • Table Middle East Cell Therapy Value Market Share by Types from 2016 to 2026

    • Table Middle East Cell Therapy Sales by Application from 2016 to 2026

    • Table Middle East Cell Therapy Sales Market Share by Application from 2016 to 2026

    • Table Middle East Cell Therapy Value by Application from 2016 to 2026

    • Table Middle East Cell Therapy Value Market Share by Application from 2016 to 2026

    • Table Africa Cell Therapy Revenue by Countries from 2016 to 2026

    • Table Africa Cell Therapy Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa Cell Therapy Revenue Market Share by Major Countries in 2020

    • Table Africa Cell Therapy Sales by Countries from 2016 to 2026

    • Table Africa Cell Therapy Sales Market Share by Countries from 2016 to 2026

      • Figure Africa Cell Therapy Sales Market Share by Major Countries in 2020

    • Figure Nigeria Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Others Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Table Africa Cell Therapy Sales by Types from 2016 to 2026

    • Table Africa Cell Therapy Sales Market Share by Types from 2016 to 2026

    • Table Africa Cell Therapy Value by Types from 2016 to 2026

    • Table Africa Cell Therapy Value Market Share by Types from 2016 to 2026

    • Table Africa Cell Therapy Sales by Application from 2016 to 2026

    • Table Africa Cell Therapy Sales Market Share by Application from 2016 to 2026

    • Table Africa Cell Therapy Value by Application from 2016 to 2026

    • Table Africa Cell Therapy Value Market Share by Application from 2016 to 2026

    • Table Oceania Cell Therapy Revenue by Countries from 2016 to 2026

    • Table Oceania Cell Therapy Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania Cell Therapy Revenue Market Share by Major Countries in 2020

    • Table Oceania Cell Therapy Sales by Countries from 2016 to 2026

    • Table Oceania Cell Therapy Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania Cell Therapy Sales Market Share by Major Countries in 2020

    • Figure Australia Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Australia Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Cell Therapy Market Value and Growth Rate from 2016 to 2026

    • Figure Others Cell Therapy Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania Cell Therapy Sales by Types from 2016 to 2026

    • Table Oceania Cell Therapy Sales Market Share by Types from 2016 to 2026

    • Table Oceania Cell Therapy Value by Types from 2016 to 2026

    • Table Oceania Cell Therapy Value Market Share by Types from 2016 to 2026

    • Table Oceania Cell Therapy Sales by Application from 2016 to 2026

    • Table Oceania Cell Therapy Sales Market Share by Application from 2016 to 2026

    • Table Oceania Cell Therapy Value by Application from 2016 to 2026

    • Table Oceania Cell Therapy Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of Cell Therapy

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of Cell Therapy with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US